Clinical Laserthermia Systems Americas, Inc.: Scientific Article Covering Immune Modulating Interstitial Laser Thermotherapy by CLS' Co-founder Professor Karl-Göran Tranberg Published in the Journal Frontiers in Oncology
Article Overview Current immune-based therapies, particularly checkpoint blockade, have improved cancer therapy in a major way, but most patients do not respond favorably to immunotherapy, pointing to the need for new or complementary approaches. Physically based Local Destruction of Tumors (LDT) methods can induce immunologic effects and contribute to anti-tumor immune activity. The present review examined abscopal effects induced by presently available local destruction methods, such as radiofrequency ablation, focal laser ablation, cryotherapy and radiotherapy, without or with combination ...